Tumor Abnormal Protein in the Diagnosis of Breast Cancer in Patients with a Palpable Mass.

Background: Tumor abnormal protein (TAP) is now gradually applied for early detection of cancers. The aim of this study was to assess the performance of serum TAP in breast cancer patients with a palpable mass.

Methods: TAP from peripheral blood of 217 breast cancer patients and 222 with benign tumors patients were compared.

Bioinformatics analysis revealing prognostic significance of gene in breast cancer.

Ribonucleotide reductase M2 subunit () plays vital roles in many cellular processes such as cell proliferation, invasiveness, migration, angiogenesis, senescence, and tumorigenesis. However, the prognostic significance of gene in breast cancer remains to be investigated. expression was initially evaluated using the Oncomine database.